Research graph
References from A Novel Dual Therapy for Diabetic Ischemic Heart Injury: Sinomenine and Liraglutide Restore Mitochondrial Homeostasis and Suppress Pyroptosis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.phymed.2024.155649
10.1016/j.phymed.2024.155649 · External reference
10.1002/mnfr.201600112
10.1002/mnfr.201600112 · External reference
10.1080/03007995.2024.2333440
10.1080/03007995.2024.2333440 · External reference
10.1016/j.eclinm.2023.102022
10.1016/j.eclinm.2023.102022 · External reference
Diabetes Mellitus: Understanding the Pathophysiology and Therapeutic Strategies
2024 · External reference
10.1007/s00395-021-00893-5
10.1007/s00395-021-00893-5 · External reference
10.3389/fcvm.2022.967115
10.3389/fcvm.2022.967115 · External reference
Unresolved reference
2019 · External reference
10.1007/s11033-022-08189-0
10.1007/s11033-022-08189-0 · External reference
10.1016/j.ejphar.2024.176464
10.1016/j.ejphar.2024.176464 · External reference
10.1016/j.arr.2023.102182
10.1016/j.arr.2023.102182 · External reference
10.1016/j.lfs.2024.122998
10.1016/j.lfs.2024.122998 · External reference
10.3389/fcell.2021.750382
10.3389/fcell.2021.750382 · External reference
10.1124/pharmrev.121.000348
10.1124/pharmrev.121.000348 · External reference
10.1016/j.jacc.2018.09.086
10.1016/j.jacc.2018.09.086 · External reference
10.1111/bph.15294
10.1111/bph.15294 · External reference
10.3390/molecules29020540
10.3390/molecules29020540 · External reference
10.1016/j.jsps.2022.04.005
10.1016/j.jsps.2022.04.005 · External reference
10.3389/fphar.2022.922484
10.3389/fphar.2022.922484 · External reference
10.1007/s11302-016-9554-z
10.1007/s11302-016-9554-z · External reference
10.1016/j.jstrokecerebrovasdis.2016.02.023
10.1016/j.jstrokecerebrovasdis.2016.02.023 · External reference
10.1016/j.mce.2023.111954
10.1016/j.mce.2023.111954 · External reference
Liraglutide Attenuates Myocardial Ischemia/Reperfusion Injury Through the Inhibition of Necroptosis by Activating GLP‐1R/PI3K/Akt Pathway
2023 · External reference
10.1113/ep093135
10.1113/ep093135 · External reference
Liraglutide‐Induced Reduction of Myocardial Ischemia Reperfusion Injury in Rats via ERK1/2 Signaling Pathway
10.4314/tjpr.v16i8.12 · 2017 · External reference
10.4103/cjop.cjop-d-23-00032
10.4103/cjop.cjop-d-23-00032 · External reference
10.3389/fcvm.2021.749113
10.3389/fcvm.2021.749113 · External reference
Liraglutide Preconditioning Attenuates Myocardial Ischemia/Reperfusion Injury via homer1 Activation
10.18632/aging.202429 · 2021 · External reference
10.1177/117739280700200015
10.1177/117739280700200015 · External reference
10.1080/21655979.2021.2000195
10.1080/21655979.2021.2000195 · External reference
From Mundane to Classic: Sinomenine as a Multi‐Therapeutic Agent
10.1111/bph.16267 · 2023 · External reference
Liraglutide Improves Myocardial Fibrosis After Myocardial Infarction Through Inhibition of CTGF by Activating cAMP in Mice
2018 · External reference
10.1002/ame2.12106
10.1002/ame2.12106 · External reference
Realizing the Therapeutic Potential of Novel Cardioprotective Therapies: The EU‐CARDIOPROTECTION COST Action‐CA16225
2018 · External reference
10.1007/s00210-023-02383-y
10.1007/s00210-023-02383-y · External reference
10.1007/s11033-023-08318-3
10.1007/s11033-023-08318-3 · External reference
10.1155/2017/9743280
10.1155/2017/9743280 · External reference
10.1016/j.bbadis.2019.05.007
10.1016/j.bbadis.2019.05.007 · External reference
10.1002/ame2.12106
10.1002/ame2.12106 · ExternalCitation · doi-reference
10.1002/mnfr.201600112
10.1002/mnfr.201600112 · ExternalCitation · doi-reference
10.1007/s00210-023-02383-y
10.1007/s00210-023-02383-y · ExternalCitation · doi-reference
10.1007/s00395-021-00893-5
10.1007/s00395-021-00893-5 · ExternalCitation · doi-reference
10.1007/s11033-022-08189-0
10.1007/s11033-022-08189-0 · ExternalCitation · doi-reference
10.1007/s11033-023-08318-3
10.1007/s11033-023-08318-3 · ExternalCitation · doi-reference
10.1007/s11302-016-9554-z
10.1007/s11302-016-9554-z · ExternalCitation · doi-reference
10.1016/j.arr.2023.102182
10.1016/j.arr.2023.102182 · ExternalCitation · doi-reference
10.1016/j.bbadis.2019.05.007
10.1016/j.bbadis.2019.05.007 · ExternalCitation · doi-reference
10.1016/j.eclinm.2023.102022
10.1016/j.eclinm.2023.102022 · ExternalCitation · doi-reference
10.1016/j.ejphar.2024.176464
10.1016/j.ejphar.2024.176464 · ExternalCitation · doi-reference
10.1016/j.jacc.2018.09.086
10.1016/j.jacc.2018.09.086 · ExternalCitation · doi-reference
10.1016/j.jsps.2022.04.005
10.1016/j.jsps.2022.04.005 · ExternalCitation · doi-reference
10.1016/j.jstrokecerebrovasdis.2016.02.023
10.1016/j.jstrokecerebrovasdis.2016.02.023 · ExternalCitation · doi-reference
10.1016/j.lfs.2024.122998
10.1016/j.lfs.2024.122998 · ExternalCitation · doi-reference
10.1016/j.mce.2023.111954
10.1016/j.mce.2023.111954 · ExternalCitation · doi-reference
10.1016/j.phymed.2024.155649
10.1016/j.phymed.2024.155649 · ExternalCitation · doi-reference
10.1080/03007995.2024.2333440
10.1080/03007995.2024.2333440 · ExternalCitation · doi-reference
10.1080/21655979.2021.2000195
10.1080/21655979.2021.2000195 · ExternalCitation · doi-reference
10.1111/bph.15294
10.1111/bph.15294 · ExternalCitation · doi-reference
From Mundane to Classic: Sinomenine as a Multi‐Therapeutic Agent
10.1111/bph.16267 · ExternalCitation · doi-reference
10.1113/ep093135
10.1113/ep093135 · ExternalCitation · doi-reference
10.1124/pharmrev.121.000348
10.1124/pharmrev.121.000348 · ExternalCitation · doi-reference
10.1155/2017/9743280
10.1155/2017/9743280 · ExternalCitation · doi-reference
10.1177/117739280700200015
10.1177/117739280700200015 · ExternalCitation · doi-reference
Liraglutide Preconditioning Attenuates Myocardial Ischemia/Reperfusion Injury via homer1 Activation
10.18632/aging.202429 · ExternalCitation · doi-reference
10.3389/fcell.2021.750382
10.3389/fcell.2021.750382 · ExternalCitation · doi-reference
10.3389/fcvm.2021.749113
10.3389/fcvm.2021.749113 · ExternalCitation · doi-reference
10.3389/fcvm.2022.967115
10.3389/fcvm.2022.967115 · ExternalCitation · doi-reference
10.3389/fphar.2022.922484
10.3389/fphar.2022.922484 · ExternalCitation · doi-reference
10.3390/molecules29020540
10.3390/molecules29020540 · ExternalCitation · doi-reference
10.4103/cjop.cjop-d-23-00032
10.4103/cjop.cjop-d-23-00032 · ExternalCitation · doi-reference
Liraglutide‐Induced Reduction of Myocardial Ischemia Reperfusion Injury in Rats via ERK1/2 Signaling Pathway
10.4314/tjpr.v16i8.12 · ExternalCitation · doi-reference
